March 25, 2019

FDA issues Safety Communication on cybersecurity vulnerabilities in Medtronic cardiac devices

By: Judy Mathias
Share

Editor’s Note

The Food & Drug Administration on March 21 issued a Safety Communication on cybersecurity vulnerabilities identified in wireless telemetry technology used for communication between Medtronic’s implantable cardiac devices, clinic programmers, and home monitors.

Medtronic (Dublin, Ireland) is working on updates to address the vulnerabilities and recommends that healthcare providers and patients continue to use these devices and follow device labeling.

Read More >>

Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat